Advertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below. Please try againArticle contentAdvertisement 3 Story continues below This advertisement has not loaded yet, but your article continues below. Article content For NeOnc, the headline is straightforward: NEO100 substantially exceeded its historical Phase 2a benchmark, delivered statistically significant results, and now advances toward its next regulatory step. Advertisement 4 Story continues below This advertisement has not loaded yet, but your article continues below. Cautionary Note Regarding Forward-Looking StatementsAdvertisement 5 Story continues below This advertisement has not loaded yet, but your article continues below.